Active Pharmaceutical Ingredients (API), popularly speaking, are the raw materials of medicines, only pharmaceutical raw materials are processed into pharmaceutical preparations , can they become medicines available for clinical use, so drugs we usually eat are the finished drugs through processing. Active Pharmaceutical Ingredients based on its sources can be divided into two major categories ,including chemical synthetic drugs and natural chemical drugs. Chemical synthetic drugs can be divided into organic synthetic drugs and inorganic synthetic drugs. Inorganic synthetic drugs are inorganic compounds ( very few is element), such as aluminum hydroxide, magnesium trisilicate which are used for the treatment of gastric and duodenal ulcers ; organic synthetic drugs are mainly composed of drugs made by basic organic chemical raw materials, through a series of organic chemical reactions (such as aspirin, chloramphenicol, caffeine, etc.). Natural chemical drugs ,based on its sources,can be divided into two categories including biochemical drugs and plant chemical drugs. Antibiotics are generally made by the microbial fermentation, which belongs to the biochemistry category. A variety of semi-synthetic antibiotics occurs in recent years,which are biosynthesis and chemical synthesis combining products.Among active Pharmaceutical Ingredients, the organic synthetic drugs varieties, yields and values have the largest proportion,which are the main pillars of the chemical and pharmaceutical industries. The quality of active Pharmaceutical Ingredients decides whether the formulation is good or bad , so its quality standards are very strict ,countries in the world have developed national pharmacopoeia standards and strict quality control methods for its widely used active Pharmaceutical ingredients.
Synthesis and Thermodynamic Properties of 1-Butyl-3-methylimidazolium hexafluorophosphate
1-Butyl-3-methylimidazolium hexafluorophosphateIt possesses unique solvation and extraction properties.
Mar 17,2026 APIChemical Properties and Preparation Methods of DL-3-Hydroxybutyric acid sodium salt
DL-3-Hydroxybutyric acid sodium salt interacts with lipids (modeled using DPPC monolayers) and alters phase behavior at clinically relevant concentrations.
Mar 17,2026 APILifitegrast: Safety and Efficacy in Dry Eye Disease
Lifitegrast is an ophthalmic immunomodulator for dry eye, blocking LFA-1/ICAM-1 to reduce inflammation. It improves symptoms safely, with mild ocular AEs.
Mar 16,2026 APICortisone Acetate: Clinical Use and Metabolic Comparison
Cortisone acetate is a classic glucocorticoid and adrenal insufficiency which requires conversion to active cortisol and shows better metabolic profile.
Mar 16,2026 APIAtosiban Acetate: Tocolytic Mechanism and Clinical Evaluation
Atosiban acetate is an receptor antagonist used to inhibit uterine contractions and delay preterm labor which reduces intracellular calcium safely.
Mar 16,2026 APIChemical Property of Tert-butyl 4-(6-aminopyridin-3-yl)piperazine-1-carboxylate
Tert-butyl 4-(6-aminopyridin-3-yl)piperazine-1-carboxylate is primarily used as a pharmaceutical chemical intermediate.
Mar 15,2026 APIPharmacokinetics and Safety of GSK1349572
GSK1349572 is indicated for use in combination with other antiretroviral agents for the treatment of HIV-1 infection in adults.
Mar 15,2026 APIBetahistine Dihydrochloride: Clinical Applications & Pharmacological Effects
Betahistine dihydrochloride is used for Meniere's disease and vertigo, and high-dose can improve cognitive function in schizophrenia patients safely.
Mar 15,2026 APISynthetic Methods of Tetrapropylammonium hydroxide
Aqueous solutions of tetrapropylammonium hydroxide (at concentrations of 25% or 40%) are widely used as biochemical reagents in life science research.
Mar 14,2026 APIQuantitative analysis and Hepatoprotective effects of L-Ornithine L-aspartate salt
L-Ornithine L-aspartate salt is composed of two naturally occurring, non-essential L-amino acids—ornithine and aspartate—and exhibits oral activity.
Mar 14,2026 API












